mailed
on 07 Jun 2024
Last Applicant/ Owned by
Bldg. 31 Rm. 2B 50
Bethesda
US
MD
20892-2111
Serial Number
98075430 filed on 07th Jul 2023
Registration Number
N/A
Correspondent Address
Thomas Dunlap DUNLAP BENNETT & LUDWIG PLLC
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Biomedical research services; Research and development, engineering, and product testing services in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; medical and scientific research in the fields of medicine, h Read More
Biomedical research services; Research and development, engineering, and product testing services in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; medical and scientific research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; technological research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; technical research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; providing medical research, biomedical research, and scientific research information in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; providing medical research, biomedical research, and scientific research information in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment via a global internet website
11th 000101
11th 000101
Educational services, namely, organizing, arranging, and conducting conferences, seminars, webinars, and trainings in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment, and distribution of training materials in connection therewith
11th 000101
11th 000101
Providing grants and financial support for research, development, engineering and testing in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment
11th 000101
11th 000101
Promoting research in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment through the support, oversight, and coordination of research projects conducted by government agencies, health departments, researchers, scientists, universities, hospitals, research foundations, and businesses; administration and management of research grants in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; promoting collaboration within the scientific, research, academic, business, and provider communities to achieve advances in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment; business management of programs related to public-private partnerships in the fields of medicine, health, biotechnology, biomedical science, genetics, vaccine production and development, immunotherapy, addressing societal challenges that affect community health, and disease prevention, detection, and treatment
11th 000101
11th 000101
Tops as clothing; bottoms as clothing; headwear; baseball caps and hats; jackets as clothing; polo shirts; t-shirts
11th 000101
11th 000101
Plastic and vinyl banners
11th 000101
11th 000101
Beverage glassware; cups and mugs; plaques of glass and crystal for use as awards
11th 000101
11th 000101
Plaques of epoxy resin plastic for use as awards
11th 000101
11th 000101
Printed educational and professional publications, namely, newsletters, fact sheets, flyers, posters, and brochures about federally funded biomedical and scientific research on human health and human diseases; adhesive note pads, pens, personal organizers
11th 000101
11th 000101
Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, flyers, posters, and brochures about federally funded biomedical and scientific research on human health and human diseases
11th 000101
11th 000101
No 98075430
No Service Mark
No 45916-011g
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
07th Jun 2024 | FINAL REFUSAL WRITTEN |
07th Jun 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
07th Jun 2024 | FINAL REFUSAL E-MAILED |
28th May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
28th May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
28th May 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
26th Feb 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
26th Feb 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
27th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
27th Nov 2023 | NON-FINAL ACTION E-MAILED |